Reports fly of Teva CEO candidate; EC official says Ireland's drug costs too high;

@FiercePharma: Thursday's top story: Novo Nordisk recruiting 400 U.S. sales reps as growth decelerates. Article | Follow @FiercePharma

@EricPFierce: FDA has new plan to arrest drug shortages. Its ultimate solution is for drugmakers to improve quality. Story | Follow @EricPFierce

@CarlyHFierce: Once again, Bayer's new drugs power pharma sales upward. ICYMI yesterday | Follow @CarlyHFierce

> News media in Israel say that Erez Vigodman, a Teva Pharmaceutical Industries ($TEVA) director and CEO of Makhteshim Agan Industries, is favored to succeed Jeremy Leivn as CEO. Article

> Mylan ($MYL) says it has been sued by Teijin Pharma Limited and Takeda Pharmaceuticals in connection with its first-to-file application to make a generic version of Uloric. Release

> An official in the EU claims the cost of drugs in Ireland cannot be justified. Story

> Authorities in India have ruled against a shareholder of Zenotech Laboratories who challenged the acquisition of the Hyderabad-based company by Ranbaxy Laboratories. Story

Medical Device News

@FierceMedDev: Sequenom vows to appeal court decision invalidating prenatal test patent. More | Follow @FierceMedDev

@MarkHFierce: PerkinElmer said the government shutdown could, in part, affect revenue projections for the year. ICYMI yesterday | Follow @MarkHFierce

@MichaelGFierce: | Follow @MichaelGFierce

> Boston Scientific closes $275M deal for Bard's electrophysiology arm. Story

> Gore begins long trek to pay back Bard in vascular graft patent ruling. Item

> Smith & Nephew reports improved Q3 and names new chairman. Article

Biotech News

@FierceBiotech: Popular yesterday: Feds launch probe of AstraZeneca's controversial late-stage Brilinta study. Article | Follow @FierceBiotech

@JohnCFierce: NovaQuest lands $459M fund for goal-line dealmaking--That's $1.2B for today. More | Follow @JohnCFierce

@DamianFierce: GlobeImmune pulls plug on $75M IPO despite still-bubbling market. Article | Follow @DamianFierce

@EmilyMFierce: Scripps Research scientists reach major milestone w/ HIV research, paving wave for new vaccine efforts. FierceBiotech Research story | Follow @EmilyMFierce

> Flailing Ariad swallows poison pill to fend off takeovers. More

> VC OrbiMed hauls in $735M fund in 'vibrant' time for biotech. News

> NovaQuest lands $459M fund for goal-line dealmaking. Story

And Finally... Piramal Enterprises has scratched an itch to broaden its OTC business with the acquisition of the skincare brand Caladryl in India from Valeant Pharmaceuticals ($VRX) for an undisclosed sum. Report

Suggested Articles

Download our solutions overview to discover how CoverMyMeds can make a difference for your brand.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.

Harout Semerjian stepped down as Immunomedics CEO after about a month in the top job, as COVID-19 made it difficult for him to relocate to the U.S.